Chen et al.
δ 8.02-8.05 (m, 2H), 7.57-7.59 (m, 1H), 7.47-7.51 (m, 2H),
3.46-3.62 (m, 3H), 3.35 (d, J ) 2.4 Hz, 1H), 2.69-2.71 (m, 1H),
2.07-2.15 (m, 1H), 1.66-1.78 (m, 2H), 1.45-1.57 (m, 1H), 1.20-
1.30 (m, 1H). NMR (CDCl3, 100 MHz) δ 196.6, 137.2, 133.8,
128.8, 128.5, 55.8, 41.5, 40.5, 37.2, 23.3, 20.3, 18.9; HR-MS (ESI)
m/z calcd for C14H17NOBr (M + H+) 294.0488, found 294.0498.
General Procedure for Dehydrobromination. To a mixture
of 2a (mixture of diastereomers), THF (200 mL), and methanol (2
mL) was added crushed potassium hydroxide (1.4 g, 25 mmol) at
room temperature and the mixture stirred for 4 h. Upon completion
(as judged by TLC), dichloromethane (500 mL) and water (300
mL) were added, the layers were then separated, and the water layer
was extracted with dichloromethane (150 mL). The combined
organic layers were washed with water (200 mL) followed by drying
over sodium sulfate, and the solvent was removed in vacuo, to give
1.70 g of (5R*,6S*)-(2-methylene-1-azabicyclo[3.1.0]hex-6-yl)-
phenylmethanone (3a, quant. yield). Further purification was
achieved on a silica gel column (hexane/ethyl acetate ) 6/4).
(5R*,6S*)-(2-Methylene-1-azabicyclo[3.1.0]hex-6-yl)phenylmeth-
anone (3a): 1H NMR (CDCl3, 400 MHz) δ 8.02-8.05 (m, 2H),
7.61-7.65 (m, 1H), 7.50-7.54 (m, 2H), 5.31 (d, J ) 1.6 Hz, 1H),
4.74 (d, J ) 1.6 Hz, 1H), 3.22-3.25 (m, 2H), 2.24-2.60 (m, 4H);
13C NMR (CDCl3, 100 MHz) δ 196.2, 158.6, 136.8, 133.3, 128.7,
128.4, 101.9, 50.6, 45.4, 26.2, 25.3; HR-MS (EI) m/z calcd for
C13H13NO 199.0997, found 199.0998.
General Procedure of Aziridine Opening with Azidotrimeth-
ylsilane. (2S*,2′S*)-2-Azido-2-(5′-methyl-3′,4′-dihydro-2H-pyr-
rol-2′-yl)-1-phenylethanone (Table 3, entry 1). To a mixture of
3a (380 mg, 1.9 mmol), dichloromethane (10 mL), and water (343
mg, 19 mmol) was added azidotrimethylsilane (440 mg, 3.8 mmol)
at room temperature and the mixture stirred overnight. Upon
completion (as judged by TLC), the solvent and other volatiles were
removed in vacuo to give 460 mg of (2S*,2′S*)-2-azido-2-(5′-
methyl-3′,4′-dihydro-2H-pyrrol-2′-yl)-1-phenylethanone (quant.
yield): 1H NMR (CDCl3, 300 MHz) δ 8.04-8.07 (m, 2H), 7.65-
7.71 (m, 1H), 7.53-7.59 (m, 2H), 5.44 (d, J ) 3.6 Hz, 1H), 4.63-
4.68 (m, 1H), 2.67-2.79 (m, 1H), 2.49-2.61 (m, 1H), 2.13 (d, J
) 1.5 Hz, 3H), 1.81-2.02 (m, 2H); 13C NMR (CDCl3, 100 MHz)
δ 194.8, 178.1, 134.9, 134.0, 129.0, 128.8, 73.8, 67.5, 39.6, 23.2,
19.7; HR-MS (ESI) m/z calcd for C13H15N4O (M + H+) 243.1240,
found 243.1246.
General Procedure of Hydrogenation of Aziridine. 2-(5′-
Methyl-3′,4′-dihydro-2H-pyrrol-2′-yl)-1-phenylethanone. (Table
3, entry 2). A mixture of 3a (20 mg, 0.1 mmol), 10% palladium
on carbon (2 mg), and methanol (1 mL) was stirred under hydrogen
(1 atm) at room temperature for 1 h. The solid was removed by
filtration and the solvent was removed from the filtrate in vacuo,
to give 20 mg of 2-(5′-methyl-3′,4′-dihydro-2H-pyrrol-2′-yl)-1-
phenylethanone (quant. yield): 1H NMR (CDCl3, 300 MHz) δ
7.99-8.02 (m, 2H), 7.56-7.61 (m, 1H), 7.46-7.51 (m, 2H), 4.53-
4.58 (m, 1H), 3.64 (dd, J ) 16.8 Hz, 4.5 Hz, 1H), 2.98 (dd, J )
16.8 Hz, 9.0 Hz, 1H), 2.53-2.61 (m, 2H), 2.26-2.37 (m, 1H),2.07
(d, J ) 1.5 Hz, 3H), 1.47-1.60 (m, 1H); 13C NMR (CDCl3, 75
MHz) δ 198.6, 175.1, 137.1, 133.1, 128.6, 128.2, 68.8, 45.5, 39.1,
29.6, 19.8.
General Procedure of Aziridine Opening with Water.
(2S*,2′S*)-2-Hydroxy-2-(5′-methyl-3′,4′-dihydro-2H-pyrrol-2′-
yl)-1-phenylethanone (Table 3, entry 4). To the mixture of 3a
(100 mg, 0.5 mmol) in dichloromethane (5 mL) was added
trifloroacetice acid (56 µL, 0.5 mmol). The reaction was stirred at
room temperature for 5 min. Sodium bicarbonate aqueous solution
(5 mL) was added. The mixture was extracted with dichloromethane
and washed with brine. The combine organic layer was dried and
concentrated. The residue was purified by silica gel column (EtOAc)
to afford (2S*,2′S*)-2-hydroxy-2-(5-methyl-3,4-dihydro-2H-pyrrol-
2-yl)-1-phenylethanone as a yellow oil (102 mg, 94%): 1H NMR
(CDCl3, 400 MHz) δ 8.01 (d, J ) 7.2 Hz, 2H), 7.60 (t, J ) 7.2
Hz, 1H), 7.48 (t, J ) 8.0 Hz, 2H), 5.59 (b, 1H), 4.42 (b, 1H), 3.81
(b, 1H), 2.52-2.62 (m, 1H), 2.31-2.42 (m, 1H), 2.05 (d, J ) 1.2
of a variety of heterocyclic products with high levels of
stereocontrol. The unprotected aziridines undergo cyclization
through addition-elimination to afford [n.1.0] strained azabi-
cyclic enamines or through addition to aldehyde to afford the
[n.1.0] hemiaminal compounds. In the presence of nucleophiles,
the strained bicyclic enamines undergo regio- and diastereose-
lective ring openings. The strain-release step affords various
cyclic imines that are not readily available using conventional
protocols. The stereospecificity of these transformations is
noteworthy. If the imine functionalities are further reduced in
the subsequent step, substituted piperidine or pyrrolidine deriva-
tives can be synthesized. Applications of this methodology in
target-oriented synthesis are in progress.
Experimental Section
General Procedure for Intramolecular Cycloamination.
Method A. To a mixture of 1a (2.5 g, 12.4 mmol), dimethoxyethane
(100 mL), and water (25 mL) was added N-bromosuccinimide (2.65
g, 14.9 mmol) at 0 °C. The mixture was stirred for 2 h in an ice
bath. After completion (as judged by TLC), 10% aqueous Na2SO3
(50 mL) and diethyl ether (100 mL) were added. The layers were
separated, and the water layer was extracted with diethyl ether (50
mL). The combined organic layers were dried over sodium sul-
fate, and the solvent was removed in vacuo. It is essential to
maintain the bath at lower than room temperature during solvent
evaporation. The residue was purified on a silica gel column
(hexane/ethyl acetate ) 6/4) to afford (2R*,5R*,6S*)-(2-bromo-
methyl-1-azabicyclo[3.1.0]hex-6-yl)phenylmethanone (1.08 g) and
(2S*,5R*,6S*)-(2-bromomethyl-1-azabicyclo[3.1.0]hex-6-yl)phenyl-
methanone (1.56 g) (2a, combined yield 76%; diastereomeric ratio
41:59). (2R*,5R*,6S*)-2a: 1H NMR (CDCl3, 400 MHz) δ 8.00-
8.02 (m, 2H), 7.61-7.64 (m, 1H),7.50-7.53 (m, 2H), 3.68-3.73
(m, 2H), 3.25-3.30 (m, 1H), 3.03 (d, J ) 2.5 Hz, 1H), 2.97 (dd,
J ) 4.5 Hz, 2.5 Hz, 1H), 2.19-2.35 (m, 2H), 2.01-2.06 (m, 1H),
1.78-1.85 (m, 1H); 13C NMR (CDCl3, 100 MHz) δ 195.9, 136.9,
133.3, 128.7, 128.2, 66.3, 49.9, 41.5, 35.7, 25.2, 24.4. (2S*,5R*,6S*)-
2a: 1H NMR (CDCl3, 400 MHz) δ 7.99-8.02 (m, 2H), 7.57-
7.61 (m, 1H), 7.46-7.50 (m, 2H), 3.68-3.75 (m, 2H), 3.48-3.52
(m, 1H), 3.27 (d, J ) 2.5 Hz, 1H), 2.93 (dd, J ) 4.5 Hz, 2.5 Hz,
1H), 2.35 (dd, J ) 14.0, 8.0, 1H), 2.12-2.19 (m, 1H), 1.95-2.01
(m, 1H), 1.37-1.44 (m, 1H); 13C NMR (CDCl3, 100 MHz) δ 195.0,
137.0, 133.3, 128.7, 128.2, 65.0, 49.1, 35.9, 33.1, 27.0, 25.1.
Method B. To a mixture of 1b (0.500 g, 2.33 mmol) and
dichloromethane (50 mL) was added N-bromosuccinimide (0.456
g, 2.56 mmol) at room temperature. The mixture was stirred for
30 min. After starting material was converted to the N-Br species
(judged by TLC, Rf ) 0.8 in ethyl acetate/hexanes ) 2/8) the
mixture was heated at 40 °C for 24 h. Toward the end of the
reaction, all of the N-Br species was consumed and precipitate
was formed. The reaction was filtrated to remove the insol-
uble material. The filtrate was concentrated and the residue was
purified on a silica gel column to afford (2R*,5R*,6S*)-(2-
bromomethyl-1-azabicyclo[4.1.0]hept-7-yl)phenylmethanone (470
mg) and (2S*,5R*,6S*)-(2-bromomethyl-1-azabicyclo[4.1.0]hept-
7-yl)phenylmethanone (132 mg) (2b, combined yield 88%; dia-
stereomeric ratio 78:22). (2R*,5R*,6S*)-2b: 1H NMR (CDCl3, 400
MHz) δ 8.00-8.03 (m, 2H), 7.56-7.61 (m, 1H), 7.48-7.51 (m,
2H), 3.64 (dd, J ) 10 Hz, J ) 6.4 Hz, 1H), 3.40 (dd, J ) 10 Hz,
J ) 7.6 Hz, 1H), 3.18 (d, J ) 3.2 Hz, 1H), 2.83-2.88 (m, 1H),
2.62-2.65 (m, 1H), 1.97-2.12 (m, 3H), 1.72-1.78 (m, 1H), 1.35-
1.39 (m, 1H), 1.16-1.22 (m, 1H). NMR (CDCl3, 100 MHz) δ
196.9, 137.1, 133.4, 128.8, 128.5, 61.8, 47.4, 42.4, 38.4, 26.7, 21.8,
17.6; HR-MS (ESI) m/z calcd for C14H17NOBr (M + H+) 294.0488,
found 294.0495. (2S*,5R*,6S*)-2b:1H NMR (CDCl3, 400 MHz)
(22) Chen, G.; Sasaki, M.; Yudin, A. K. Tetrahedron Lett. 2006, 47,
255-259.
6072 J. Org. Chem., Vol. 71, No. 16, 2006